Ista Pharma reports positive Prolensa Phase 3 trial results
Prolensa is a once-daily topical nonsteroidal anti-inflammatory (NSAID) compound which is used to treat ocular inflammation and pain following cataract surgery.. The two Phase 3 controlled, double-masked, multi-center,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.